Mussa, A.; Carli, D.; Giorgio, E.; Villar, A.M.; Cardaropoli, S.; Carbonara, C.; Campagnoli, M.F.; Galletto, P.; Palumbo, M.; Olivieri, S.;
et al. MEK Inhibition in a Newborn with RAF1-Associated Noonan Syndrome Ameliorates Hypertrophic Cardiomyopathy but Is Insufficient to Revert Pulmonary Vascular Disease. Genes 2022, 13, 6.
https://doi.org/10.3390/genes13010006
AMA Style
Mussa A, Carli D, Giorgio E, Villar AM, Cardaropoli S, Carbonara C, Campagnoli MF, Galletto P, Palumbo M, Olivieri S,
et al. MEK Inhibition in a Newborn with RAF1-Associated Noonan Syndrome Ameliorates Hypertrophic Cardiomyopathy but Is Insufficient to Revert Pulmonary Vascular Disease. Genes. 2022; 13(1):6.
https://doi.org/10.3390/genes13010006
Chicago/Turabian Style
Mussa, Alessandro, Diana Carli, Elisa Giorgio, Anna Maria Villar, Simona Cardaropoli, Caterina Carbonara, Maria Francesca Campagnoli, Paolo Galletto, Martina Palumbo, Simone Olivieri,
and et al. 2022. "MEK Inhibition in a Newborn with RAF1-Associated Noonan Syndrome Ameliorates Hypertrophic Cardiomyopathy but Is Insufficient to Revert Pulmonary Vascular Disease" Genes 13, no. 1: 6.
https://doi.org/10.3390/genes13010006
APA Style
Mussa, A., Carli, D., Giorgio, E., Villar, A. M., Cardaropoli, S., Carbonara, C., Campagnoli, M. F., Galletto, P., Palumbo, M., Olivieri, S., Isella, C., Andelfinger, G., Tartaglia, M., Botta, G., Brusco, A., Medico, E., & Ferrero, G. B.
(2022). MEK Inhibition in a Newborn with RAF1-Associated Noonan Syndrome Ameliorates Hypertrophic Cardiomyopathy but Is Insufficient to Revert Pulmonary Vascular Disease. Genes, 13(1), 6.
https://doi.org/10.3390/genes13010006
